(HBIO) on Tuesday reported a loss of $2.9 million in its second quarter. On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 64 cents. Losses, adjusted for non-recurring costs and amortization costs, came to 14 cents per share.
The medical instruments maker posted revenue of $22.7 million in the period. For the current quarter ending in September, Harvard Bioscience said it expects revenue in the range of $21 million to $22.6 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.
Access a Zacks stock report on HBIO at https://www.zacks.com/ap/HBIO Source ROSH HA AYIN, Israel (AP) — ROSH HA AYIN, Israel (AP) — Ceragon Networks Ltd. (CRNT) on Tuesday reported a loss of $2.1 million in its second quarter.
On a per-share basis, the Rosh Ha Ayin, Israel-based company said it had a loss of 2 cents. Earnings, adjusted for non-recurring costs and restructuring costs, came to 2 cents per share. The provider of wireless backhaul services posted revenue of $93.9 million in the period.
Ceragon expects full-year revenue in the range of $355 million to $385 million. Access a Zacks stock report on CRNT at https://www.zacks.com/ap/CRNT Source
Summary from source